Study participants shown by sampling category and country
| Country | Demographic surveillance site | Healthcare worker | People living with HIV | Family member of a deceased | ||
| Diagnosed, not on ART | On ART* | LTFU† | ||||
| Uganda | Rakai | 6 | 15 | 15 | 6 | 8 |
| Uganda | Kyamulibwa | 5 | 8 | 8 | 4 | 5 |
| Kenya | Kisumu | 8 | 10 | 15 | 6 | 11 |
| Tanzania | Kisesa | 7 | 13 | 20 | 4 | 6 |
| Malawi | Karonga | 5 | 9 | 20 | 4 | 6 |
| Zimbabwe | Manicaland | 4 | 16 | 35 | 8 | 6 |
| South Africa | uMkhanyakude | 18 | 1616 | 17 | 6 | 6 |
| Total | 53 | 87 | 130 | 38 | 48 | |
*ART: the PLHIV could have been taking ART for variable periods of time; countries had varying cut-off points but generally captured recently initiated and then longer term (over 5 years).
†LTFU: PLHIV had not collected ART from their registered clinic for a country-specific predetermined period of time.
ART, antiretroviral therapy; LTFU, lost to follow-up.